Cover Image
市場調查報告書

Archer Pharmaceuticals, Inc. :產品平台分析

Archer Pharmaceuticals, Inc. - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 226247
出版日期 內容資訊 英文 24 Pages
訂單完成後即時交付
價格
Back to Top
Archer Pharmaceuticals, Inc. :產品平台分析 Archer Pharmaceuticals, Inc. - Product Pipeline Review - 2015
出版日期: 2015年04月15日 內容資訊: 英文 24 Pages
簡介

Archer Pharmaceuticals, Inc. 是開發老年癡呆症治療藥的製藥公司。該公司還有進行標的發現、新藥發現、目標檢驗、臨床前有效性、小規模製造、第Ⅰ/Ⅱ相臨床試驗、開發新藥、全球規模的行銷及授權。

本報告提供Archer Pharmaceuticals, Inc.的治療藥開發平台的現狀及各開發階段比較分析、各藥物標的、作用機制、給藥途徑、分子類型的治療藥的評估、最新的企業新聞和發表、後期階段及中止的計劃相關資訊等。

Archer Pharmaceuticals, Inc.的基本資料

  • Archer Pharmaceuticals, Inc.概要
  • 主要資訊
  • 企業資料

Archer Pharmaceuticals, Inc.:R&D概要

  • 主要的治療範圍

Archer Pharmaceuticals, Inc.:開發平台的檢討

  • 各開發階段的開發中產品
  • 單劑產品

Archer Pharmaceuticals, Inc.:開發中產品概況

  • 最後階段的開發中產品
    • 第三階段的產品/聯合治療模式
  • 臨床實驗階段的開發中產品
    • 第一階段的產品/聯合治療模式
  • 初期階段的開發中產品
    • 在前臨床階段的產品/聯合治療模式

Archer Pharmaceuticals, Inc.:藥物簡介

  • nilvadipine
  • ARC-031
  • ARC-050
  • ARC-069

Archer Pharmaceuticals, Inc.:開發平台分析

  • 各標靶
  • 各分子類型
  • 各作用機制

Archer Pharmaceuticals, Inc.:最近的開發平台趨勢

Archer Pharmaceuticals, Inc.:暫停中的計劃

Archer Pharmaceuticals, Inc.:總公司和子公司的所在地

附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC06934CDB

Summary

Global Markets Direct's, 'Archer Pharmaceuticals, Inc. - Product Pipeline Review - 2015', provides an overview of the Archer Pharmaceuticals, Inc.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Archer Pharmaceuticals, Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Archer Pharmaceuticals, Inc. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Archer Pharmaceuticals, Inc.'s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Archer Pharmaceuticals, Inc.'s pipeline products

Reasons to buy

  • Evaluate Archer Pharmaceuticals, Inc.'s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Archer Pharmaceuticals, Inc. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Archer Pharmaceuticals, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Archer Pharmaceuticals, Inc. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Archer Pharmaceuticals, Inc.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Archer Pharmaceuticals, Inc. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Archer Pharmaceuticals, Inc. Snapshot
    • Archer Pharmaceuticals, Inc. Overview
    • Key Information
    • Key Facts
  • Archer Pharmaceuticals, Inc. - Research and Development Overview
    • Key Therapeutic Areas
  • Archer Pharmaceuticals, Inc. - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • Archer Pharmaceuticals, Inc. - Pipeline Products Glance
    • Archer Pharmaceuticals, Inc. - Late Stage Pipeline Products
      • Phase III Products/Combination Treatment Modalities
    • Archer Pharmaceuticals, Inc. - Clinical Stage Pipeline Products
      • Phase I Products/Combination Treatment Modalities
    • Archer Pharmaceuticals, Inc. - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
  • Archer Pharmaceuticals, Inc. - Drug Profiles
    • nilvadipine
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • ARC-031
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • ARC-050
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • ARC-069
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Archer Pharmaceuticals, Inc. - Pipeline Analysis
    • Archer Pharmaceuticals, Inc. - Pipeline Products by Target
    • Archer Pharmaceuticals, Inc. - Pipeline Products by Molecule Type
    • Archer Pharmaceuticals, Inc. - Pipeline Products by Mechanism of Action
  • Archer Pharmaceuticals, Inc. - Recent Pipeline Updates
  • Archer Pharmaceuticals, Inc. - Dormant Projects
  • Archer Pharmaceuticals, Inc. - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Archer Pharmaceuticals, Inc., Key Information
  • Archer Pharmaceuticals, Inc., Key Facts
  • Archer Pharmaceuticals, Inc. - Pipeline by Indication, 2015
  • Archer Pharmaceuticals, Inc. - Pipeline by Stage of Development, 2015
  • Archer Pharmaceuticals, Inc. - Monotherapy Products in Pipeline, 2015
  • Archer Pharmaceuticals, Inc. - Phase III, 2015
  • Archer Pharmaceuticals, Inc. - Phase I, 2015
  • Archer Pharmaceuticals, Inc. - Preclinical, 2015
  • Archer Pharmaceuticals, Inc. - Pipeline by Target, 2015
  • Archer Pharmaceuticals, Inc. - Pipeline by Molecule Type, 2015
  • Archer Pharmaceuticals, Inc. - Pipeline Products by Mechanism of Action, 2015
  • Archer Pharmaceuticals, Inc. - Recent Pipeline Updates, 2015
  • Archer Pharmaceuticals, Inc. - Dormant Developmental Projects,2015

List of Figures

  • Archer Pharmaceuticals, Inc. - Pipeline by Stage of Development, 2015
  • Archer Pharmaceuticals, Inc. - Monotherapy Products in Pipeline, 2015
  • Archer Pharmaceuticals, Inc. - Pipeline by Top 10 Target, 2015
  • Archer Pharmaceuticals, Inc. - Pipeline by Top 10 Molecule Type, 2015
  • Archer Pharmaceuticals, Inc. - Pipeline Products by Top 10 Mechanism of Action, 2015
Back to Top